Author

Linda C. Ulrich

Observed names: L Ulrich, Linda Ulrich

Institution: United States Food and Drug Administration

Observed institutions: National Institutes of Health, United States Food and Drug Administration, National Heart, Lung, and Blood Institute

OpenAlex ID: A5082407754

FDA’s Pediatric Device Consortia: National Program Fosters Pediatric Medical Device Development

2013 · Linda C. Ulrich, Francesca D. Joseph, et al. · PEDIATRICS · 52

Meeting the Demand for Pediatric Clinical Trials

2014 · Edward M. Connor, William E. Smoyer, et al. · Science Translational Medicine · 28

Structural requirements for anthracycline-induced cardiotoxicity and antitumor effects

1989 · Yogendra Singh, Linda Ulrich, et al. · Toxicology and Applied Pharmacology · 21

Efforts to develop orphan drugs: The FDA experience

2010 · Linda C. Ulrich · Pharmaceuticals Policy and Law · 3

Paediatric device development

2010 · Linda C. Ulrich · Pharmaceuticals Policy and Law · 3

[Clinical and experimental contribution concerning the pathogenesis of acute life-threatening complications during neck anaesthesia].

1975 · A R Stofer, L Ulrich, et al. · PubMed · 1

Ventilation changes in persons exposed to glass dust.

1982 · Linda C. Ulrich, O. Veselá, et al. · Pracovní lékařství

[Clinical and experimental contribution to the pathogenesis of acute life-threatening incidents following neck anesthesia].

1975 · A R Stofer, L Ulrich, et al. · PubMed

Works count: 8

Citation count: 108

H-index: 3

I10-index: 3